Cellebrite DI Ltd. (NASDAQ: CLBT) is rated one of the best stocks under $20 for the long term, with positive fiscal Q2 2025 results and a new CEO. Revenue grew 18% to $113.3 million, with ARR up 21% to $418.9 million, while net income reached $19.5 million.

The company provides digital investigative solutions for various sectors, offering services like value realization, training, technical customer support, and advanced services. While CLBT shows investment potential, other AI stocks may offer greater upside and less downside risk. Check out the report on the best short-term AI stock for more information.

Read more at Yahoo Finance: Craig-Hallum Reiterates a Buy Rating on Cellebrite DI Ltd. (CLBT)